- Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients
Mamatha Bhat et al, 2023, Cancer Medicine CrossRef - Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
Mamatha Bhat et al, 2015, Clinical Transplantation CrossRef - Liver Transplantation for Other Cancers
Sandra Garcia-Aroz et al, 2018, Primary and Metastatic Liver Tumors CrossRef - Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients
Mamatha Bhat et al, 2018, Mayo Clinic Proceedings CrossRef - EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway
Yi Wang et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef - De novo malignancies after liver transplantation: The effect of immunosuppressionn-personal data and review of literature
Tommaso Maria Manzia et al, 2019, World Journal of Gastroenterology CrossRef - Cancers solides après transplantation d’organe : épidémiologie, pronostic et spécificités de prise en charge
Aude Guillemin et al, 2017, Bulletin du Cancer CrossRef